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Abstract
Background: A criticism of Randomized Controlled Trials (RCTs) in primary care is that they lack
external validity, participants being unrepresentative of the wider population. Our aim was to
determine whether published primary care-based RCTs report information about how the study
sample is assembled, and whether this is associated with RCT characteristics.
Methods: We reviewed RCTs published in four primary care journals in the years 2001–2004.
Main outcomes were: (1) eligibility fraction (proportion eligible of those screened), (2) enrolment
fraction (proportion randomised of those eligible), (3) recruitment fraction (proportion of
potential participants actually randomised), and (4) number of patients needed to be screened
(NNS) in order to randomize one participant.
Results: A total of 148 RCTs were reviewed. One hundred and three trials (70%) reported the
number of individuals assessed by investigators for eligibility, 119 (80%) reported the number
eligible for participation, and all reported the actual number recruited. The median eligibility
fraction was 83% (IQR 40% to 100%), and the median enrolment fraction was 74% (IQR 49% to
92%). The median NNS was 2.43, with some trials reportedly recruiting every patient or practice
screened for eligibility, and one trial screening 484 for each patient recruited. We found no
association between NNS and journal, trial size, multi- or single-centre, funding source or type of
intervention. There may be associations between provision of sufficient recruitment data for the
calculation of NNS and funding source and type of intervention.
Conclusion: RCTs reporting recruitment data in primary care suggest that once screened for
eligibility and found to match inclusion criteria patients are likely to be randomized. This finding
needs to be treated with caution as it may represent inadequate identification or reporting of the
eligible population. A substantial minority of RCTs did not provide sufficient information about the
patient recruitment process.
Published: 19 January 2009
BMC Family Practice 2009, 10:5 doi:10.1186/1471-2296-10-5
Received: 15 September 2008
Accepted: 19 January 2009
This article is available from: http://www.biomedcentral.com/1471-2296/10/5
© 2009 Jones et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7
(page number not for citation purposes)
BMC Family Practice 2009, 10:5 http://www.biomedcentral.com/1471-2296/10/5Background
Randomized controlled trials (RCTs) are regarded as the
gold standard for determining the effectiveness of medical
interventions.[1] In order to improve the quality of RCT's,
reporting standards have been developed that relate to the
design, conduct, analysis and interpretation when submit-
ting a report on an RCT to a peer-review journal. These
explicit standards- the Consolidated Standards of Report-
ing Trials (CONSORT) enables readers to understand an
RCT's conduct and assess the validity of its results.[2]
The issue of external validity or generalizability of an RCT
arises when judgements have to be made in relation to
applying RCT evidence to an individual patient.[3,4] The
more similar a patient is to those recruited to an RCT, the
more confident a clinician can be in applying that RCT's
results back to an individual patient. Unfortunately, there
is accumulating evidence that participants recruited to
RCTs differ in important aspects to those patients seen in
primary care settings. For example, patients in RCTs of
hypertension are more often younger, male, at lower car-
diovascular risk and have less co-morbidity than patients
in primary care.[5,6] In the case of patients with asthma or
chronic obstructive pulmonary disease over 90% would
not have met inclusion criteria for RCTs on which treat-
ment recommendations and clinical guidelines are
based.[7,8]
The CONSORT checklist focuses primarily on improved
reporting of information relating to the internal validity
of an RCT.[2] The revised template for the CONSORT flow
diagram starts at the stage of asking investigators to state
the number of participants who were assessed for eligibil-
ity for the RCT. This assumes that all eligible individuals
were approached to participate in an RCT. Most research-
ers know that this is usually not the case, particularly
when investigators rely on clinicians to recruit incident
cases in situations when clinical contact time is short- for
example in patients with acute respiratory illness.[9] For
non-acute illness, ensuring high external validity can be
equally challenging; research ethics committees now
insist that approaches to patients to take part in research
requires that initial contact be made through family prac-
tices, not through the research team. This limits the ability
of researchers to know whether or not the complete target
population have been approached to take part in their
research study. RCTs based in primary care have shown
that there is a highly variable rate of recruitment within
individual family physicians and between individual fam-
ily practices.[10,11]
The aim of this study was to assess the external validity of
RCTs published in four primary care journals by quantify-
ing the selection process of trial enrolees from the primary
care population.
Methods
Data sources and collection
We reviewed RCTs published in four primary care journals
in the years 2000–2004: BMJ (primary care section), Brit-
ish Journal of General Practice, Family Practice and The Jour-
nal of Family Practice.
We collected the following data fields from each RCT:
• Citation details- title, journal citation; author contact
email.
• Characteristics of RCT and funding source- individual,
cluster based, factorial, cross-over RCT; number practices/
patients recruited per arm of RCT; number and type of
interventions; country and setting of RCT; funding source-
public (NIH, NHS, MRC, Wellcome Trust, Charity), phar-
maceutical, self funding.
• Features concerning patient population and recruitment
process- inclusion/exclusion criteria in RCT; statement
concerning target population; potential population; eligi-
ble population and participation; details concerning tar-
get population engagement; details concerning eligibility
screening; details concerning enrolment of eligible popu-
lation; statement whether incident cases or prevalent cases
were recruited; how patient population was identified-
during consultation, disease/practice register, other
method; statement of how and who approached eligible
cases – by family physician, researcher, other; statement of
method of where and in what circumstances eligible pop-
ulation were enrolled- family physician during clinic,
family physician by post, practice nurse, waiting room,
other; control group event rate.
Data extraction
Two data extractors (RJ and ROJ) independently assessed
and extracted relevant data from each published RCT. A
Microsoft ACCESS® database was used to collate relevant
details and the completed dataset was imported into
Stata® statistical package for analysis. Disagreement was
resolved involvement of a third author (TF) and a consen-
sus decision reached. CM and AM analysed the dataset,
independent of the two data extractors. Table 1 provides
definitions of the RCT recruitment terminology. Eligibil-
ity, enrolment and recruitment fractions were calculated
in the same way as Gross et al.[12]
Statistical Analysis
We summarized RCT characteristics as proportions and
compared groups using the chi-squared test. We calcu-
lated the median Number Needed to Screen (NNS) to ran-
domize one participant and assessed if the NNS, and
reporting of data required to calculate the NNS, was
related to the following explanatory variables: journal inPage 2 of 7
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RCT; whether the RCT was single or multicentre; funding
source and the type of intervention studied.
Results
Descriptive statistics
A total of 148 RCTs were reviewed. As three of the four
journals assessed are published in the UK, it was not sur-
prising to find that the majority of RCTs originated from
there (56%), with other significant contributions from the
US (10%) and the Netherlands (8%). The main funding
source was government agency (57%), most were multi-
centre (79%), and 17% had at least 650 participants. One
hundred and three RCTs (70%) reported the number of
individuals assessed by investigators for eligibility, 119
(80%) reported the number eligible for participation, and
all reported the actual number recruited (Table 2).
Recruitment statistics
Of the trials that reported quantitative recruitment infor-
mation, the median eligibility fraction was 83% (IQR
40% to 100%), and the median enrolment fraction was
74% (IQR 49% to 92%). The recruitment fraction could
be calculated for 103 trials (70%), with a median partici-
pant recruitment of 41% (IQR 16% to 71%) (Table 3).
The median NNS was 2.43 (IQR 1.41 to 6.25), with some
Table 1: RCT Recruitment Terminology
Term Definition
Target population Location and characteristics of potentially eligible individuals, representing the patient 
population to whom the results of the RCT are expected to apply
Eligibility fraction Proportion of potential participants who undergo screening and are eligible to enrol in the 
RCT
Enrolment fraction Proportion of people who are eligible for participation and who actually enrol in the RCT
Recruitment fraction Proportion of potential participants who actually enrol in the RCT
Number of patients needed to be screened (NNS) Number of patients screened in order to randomise one participant 
(equal to 1/recruitment fraction)
Table 2: Characteristics of included RCTs in terms of total, eligible and recruited population *
Characteristic Total Trials (%) Trials That Reported Target 
Population
Trials That Reported Number of 
Patients Eligible
Total RCTs 148 (100) 103 (70) 119 (80)
Journal
BMJ 58 (39) 44 (39) 50 (42)
British Journal of General Practice 46 (31.0) 31 (30) 36 (30)
Family Practice 24 (16) 17 (15) 19 (16)
Journal of Family Practice 20 (14) 11 (17) 14 (12)
Number of enrolees
<100 48 (32) 40 (39) 44 (37)
110–260 51 (34) 31 (30) 37 (31)
260–650 24 (16) 15 (15) 19 (16)
>650 25 (17) 17 (17) 19 (16)
Multicentre
Multiple 116 (79) 83 (81) 94 (80)
Single 27 (18) 16 (16) 21 (18)
Unclear 4 (3) 3 (3) 3 (3)
Funding Source
Charity 15 (13) 10 (12) 13 (14)
Governing body 5 (4) 3 (4) 3 (3)
Government 66 (57) 55 (65) 60 (63)
Pharmaceutical Industry 15 (12) 8 (9) 10 (10)
Other 14 (13) 9 (11) 10 (10)
Intervention Studied
Counselling/Lifestyle 11 (8) 8 (8) 10 (8)
Decision Support aids 7 (5) 6 (6) 7 (6)
Educational 26 (18) 21 (21) 23 (14)
Pharmaceutical therapy 23 (16) 9 (9) 11 (9)
Surgery/procedure 3 (2.0) 3 (3) 3 (3)
Other 76 (52) 55 (54) 64 (54)Page 3 of 7
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screened for eligibility, and one trial screening 484 for
each patient recruited. We found no association between
magnitude of the NNS and journal publication, RCT size,
multi- or single-centre RCT, funding source or type of
intervention (Table 4). The data suggested that trials
funded by government of interventions other than phar-
maceutical therapies may be more likely to provide suffi-
cient recruitment data for calculation of NNS (Table 5).
Discussion
Findings
We found that the reporting of recruitment to RCTs based
in primary care is inconsistent and frequently incomplete.
Of the 148 RCTs published, 103 (70%) reported the
number of individuals who were screened for eligibility
and 80% of published RCTs reported the number of indi-
viduals who were eligible. In those RCTs that did report
on the recruitment process there appears to be marked
variation in terms of the proportion of individuals who
are recruited. These findings suggest that reporting of
RCTs should be improved and that for some RCTs exter-
nal validity is limited because only a low proportion of
eligible participants are successfully recruited.
Context of previous studies
Our findings differ with those of a recent study that report
on the recruitment process in 172 RCTs published in four
general medical journals- Annals of Internal Medicine,
JAMA, The New England Journal of Medicine and The Lan-
Table 3: Eligibility, enrolment and recruitment fractions (n = 155)
Data Trials That Reported Data Median Interquartile Range
n %
Eligibility Fraction 102 83 40–100
Enrolment Fraction 119 74 49–92
Recruitment Fraction 103 41 16–71
Table 4: Relationship between Number of patients Needed to Screen (NNS) to identify one participant and RCT characteristics
Characteristics Total Trials Median Number Needed to Screen to Identify One Participant 
(Interquartile Range)
P Value
Total 103
Journal 0.78
BMJ 44 2.95 (1.42–9.30)
British Journal of General Practice 31 2.30 (1.38–4.42)
Family Practice 17 1.81 (1.23–3.46)
Journal of Family Practice 11 2.79 (1.95–7.92)
Number of enrolees 0.40
<100 40 3.15 (1.63–5.64)
110–260 31 2.19 (1.22–9.95)
260–650 15 1.66 (1.32–3.11)
>650 17 2.78 (1.38–5.16)
Multicentre
Multiple 83 2.79 (1.42–6.33)
Single 16 2.05 (1.18–7.83)
Unclear 3 1.66 (1.60–5.95)
Funding Source 0.09
Charity 10 2.61 (1.23–4.48)
Governing body 3 1.60(1.60–6.06)
Government 55 2.14 (1.34–6.33)
Pharma Industry 8 3.98 (2.10–15.59)
Other 9 5.33 (1.95–7.92)
Not Listed 18 2.62 (1.23–3.48)
Intervention Studied 0.47
Counselling/Lifestyle 8 4.75 (2.05–169.71)
Decision Support aids 6 2.89 (1.42–17.21)
Educational 21 2.05 (1.34–3.63)
Pharmaceutical therapy 9 1.89 (1.66–5.16)
Surgery/procedure 3 1.59 (1.11–9.95)
Other 55 2.79 (1.42–6.38)Page 4 of 7
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industry sponsored and over two thirds were of a pharma-
ceutical intervention, 52% of RCTs reported the number
of persons who were evaluated by investigators for eligi-
bility compared with 70% of primary-care based RCTs;
similarly 43% of the RCTs published in general medical
journals reported on the number of persons who were
actually eligible for participation, compared with 80% of
RCTs published in primary care journals.[12] These
higher figures for screening eligibility and proportion
being eligible in primary care journals need to be viewed
cautiously. Higher screening and eligibility may represent
under-reporting concerning the processes used to identify
the eligible individuals in primary care-based RCTs. Qual-
itative research has shown that difficulty in recruiting
patients is the most frequently mentioned problem in pri-
mary care-based RCTs.[13] The administrative processes
that are used to identify and quantify the eligible popula-
tion of patients may be incomplete with the consequence
that those RCTs that report complete recruitment of all eli-
gible patients may be based on an under-estimated
denominator population. Consequently, the reported
median eligibility (65), enrolment (93) and recruitment
(54) fractions in this study should be treated with some
caution (Table 3).
It has been recognized that patients seen in primary care
settings may be significantly different to patients seen in a
hospital (secondary or tertiary) care setting. Primary care
patients are more likely to have a lower probability of dis-
ease; have a milder severity of disease; and have more
undifferentiated symptoms.[14] These factors may influ-
ence both the estimated benefits and harms from treat-
ment, making the risk:benefit ratio for some interventions
less compelling for patients in primary care compared to
those in secondary care.[3] More recent evidence has have
shown that RCTs published in major medical journals do
not always clearly report exclusion criteria.[15] Further-
more, women, children, the elderly and those with com-
mon medical conditions are frequently excluded from
RCTs; and pharmaceutical-sponsored and multi-centred
RCTs in both primary and secondary care are also likely to
Table 5: Relationship between provision of data required to calculate NNS and RCT characteristics
Characteristics Data required to calculate NNS provided in report, n(%) Odds Ratio (95% CI) P Value
NO YES
(n = 45) (n = 103)
Journal 0.37
BMJ 14 (31) 44 (43) -
British Journal of General Practice 15 (33) 31 (30) 0.66 (0.28 to 1.56)
Family Practice 7 (16) 17 (16) 0.77 (0.27 to 2.24)
Journal of Family Practice 9 (20) 11 (11) 0.39 (0.13 to 1.13)
Number of enrolees 0.09
<100 8 (18) 40 (39) -
110–260 20 (44) 31 (30) 0.31 (0.12 to 0.80)
260–650 9 (20) 15 (15) 0.33 (0.11 to 1.02)
>650 8 (18) 17 (16) 0.42 (0.14 to 1.32)
Multicentre 0.45
Multiple 33 (73) 83 (81) -
Single 11 (24) 16 (16) 0.58 (0.24 to 1.38)
Unclear 1 (2) 3 (3) 1.19 (0.12 to 11.88)
Funding Source
Charity 5 (11) 10 (10) -
Governing body 2 (4) 3 (3) 0.75 (0.09 to 6.04)
Government 11 (24) 55 (53) 2.5 (0.71 to 8.76)
Pharmaceutical Industry 7 (16) 8 (8) 0.57 (0.13 to 2.50)
Other 5 (11) 9 (9) 0.9 (0.19 to 4.17)
Not Listed 15 (33) 18 (17) 0.6 (0.17 to 2.14)
Intervention Studied 0.02
Counselling/Lifestyle 3 (7) 8 (8) -
Decision Support aids 1 (2) 6 (6) 2.25 (0.18 to 27.37)
Educational 5(11) 21 (21) 1.56 (0.30 to 8.17)
Pharmaceutical therapy 14 (32) 9 (9) 0.24 (0.05 to 1.16)
Surgery/procedure 0 (0) 3 (3) undefined
Other 21 (48) 55 (54) 0.98 (0.24 to 4.06)Page 5 of 7
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other forms of RCTs.[15] Rather than rely on intuition
and judgement, it would be better to include
Implications
The implications of this study relate to improved report-
ing and recruitment in primary care-based RCTs, and in
assisting planning of future studies. Flow diagrams are
associated with improved reporting of RCTs, [16] and
implementation of the CONSORT statement has been
shown to improve the quality of published RCTs, particu-
larly in relation to dimensions of internal validity.[17]
Findings from this study suggest that greater attention to
the details of the patient recruitment process may simi-
larly influence and improve reporting of RCTs in terms of
external validity.[4,18] There are specific issues that relate
to recruitment of patients in primary care that are chal-
lenging, such as reliance on family physicians to recruit at
the time of a consultation, engaging and running an RCT
across many different family practice centres, lack of
patient sampling frames and low rates of patient refer-
ral.[11,19] More explicit reporting allied to strategies that
are known to be important ingredients in terms of
improved recruitment- good organization, simplified
documentation and study procedures, and anticipating
doctor and patient concerns about prior beliefs relating to
efficacy and side effects – are issues that need to be consid-
ered at the outset when starting up a primary care-based
RCT.[20] Complete and accurate reporting of recruitment
in published trials will also greatly assist in planning
future studies. Researchers can make more realistic esti-
mates of the resources required if the likely eligibility and
recruitment fractions are known to be low. Lastly, a low
enrolment fraction may not necessarily represent an RCT
with poor external validity. If the sample of patients
recruited is representative of the eligible population in
terms of demographic and clinical characteristics, then
external validity is high. This requires investigators to be
explicit in describing the recruitment process as well as
reporting the characteristics of those eligible individuals
included in the RCT and those eligible individuals who
were excluded from the RCT.
Shortcomings
Not withstanding concerns about identification of the full
eligible population in some RCTs mentioned above, this
study may have other shortcomings. The findings of our
study relate to three primary care journals that have a UK/
European focus. Only one of the journals selected has a
North American focus. It may be that RCTs relevant to pri-
mary care are published in general medical and North
American based journals and may provide better report-
ing of issues that relate to external validity. For this reason
further assessment concerning the external validity of
RCTs in other countries and journals is needed. On a
more positive note, investment in primary care research
and development in the UK has meant that in absolute
terms the number of RCTs published in these three UK
journals has nearly doubled compared to a five year
period in the early 1990's.[21]
Conclusion
There is room for improvement in the reporting of dimen-
sions that relate to the external validity of RCTs in primary
care, particularly in identification and reporting of the eli-
gible population. Enhancing the external validity of pri-
mary care-based RCTs requires improved reporting
alongside pragmatic strategies to enhance recruitment and
retention.
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